BBP

Equity ETFs

Sarepta Therapeutics Helps Biotech ETFs Buck Market Trend

By Max ChenJune 19, 2018

Equity ETFs

Rising Rates May Hurt Small-Cap Biotech ETF Valuations

By Max ChenDecember 23, 2016

Equity ETFs

Biotech ETFs Will Enjoy a More Favorable Environment

By Max ChenNovember 29, 2016

Equity ETFs

ETF Winners and Losers of President-Elect Trump

By Max ChenNovember 9, 2016

Featured

BBP: An Outperforming Biotechnology ETF

By Max ChenJuly 21, 2016

Equity ETFs

Biotech ETFs Rally as Earnings Boost Optimism

By Max ChenJuly 20, 2016

Equity ETFs

A Biotech ETF Proving Immune to Hawkish Fed Policy Changes

By Brenton GarenMay 4, 2016

Equity ETFs

Hit The Lab With These 17 Biotech ETFs

By Tom LydonMay 2, 2016

Featured

Why This Biotech ETF Keeps Surging

By Todd ShriberJuly 15, 2015

Featured

Investors Were Prepared for the Biotech Breakout

By Todd ShriberJune 19, 2015

Featured

BioShares Biotech ETFs Boost Lineups, Increase Diversity

By Todd ShriberJune 17, 2015

Featured

A New Biotech ETF Could Challenge Established Rivals

By Todd ShriberJune 3, 2015

Featured

Biotech ETF Run not Over Yet, Says Analyst

By Todd ShriberApril 21, 2015

Featured

Reasons to bet on new Breed Biotech ETFs

By Todd ShriberApril 17, 2015

Featured

These ETFs Will Like the Dyax News

By Todd ShriberApril 1, 2015

Featured

Virtus Acquires Majority Stake in ETF Issuer Solutions

By Tom LydonJanuary 27, 2015

Featured

New ETFs Could Benefit From Favorable Biotech Seasonality

By Todd ShriberJanuary 6, 2015

Featured

Two Unique Biotech ETFs Debut

By Tom LydonDecember 17, 2014